Global AI Medical Imaging Software for Lung Diseases Market Growth (Status and Outlook) 2024-2030

Global AI Medical Imaging Software for Lung Diseases Market Growth (Status and Outlook) 2024-2030

AI medical imaging software for lung diseases leverages artificial intelligence to automatically analyze medical images such as CT scans and X-rays, assisting physicians in detecting and diagnosing various lung conditions, including lung nodules, pneumonia, and chronic obstructive pulmonary disease (COPD). The software utilizes deep learning algorithms to identify abnormalities and offers precise localization and classification suggestions, enhancing diagnostic accuracy and efficiency. It also supports early disease detection and aids in clinical decision-making, reducing the workload on healthcare professionals.

The global AI Medical Imaging Software for Lung Diseases market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “AI Medical Imaging Software for Lung Diseases Industry Forecast” looks at past sales and reviews total world AI Medical Imaging Software for Lung Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected AI Medical Imaging Software for Lung Diseases sales for 2023 through 2029. With AI Medical Imaging Software for Lung Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Medical Imaging Software for Lung Diseases industry.

This Insight Report provides a comprehensive analysis of the global AI Medical Imaging Software for Lung Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Medical Imaging Software for Lung Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Medical Imaging Software for Lung Diseases market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Medical Imaging Software for Lung Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Medical Imaging Software for Lung Diseases.

United States market for AI Medical Imaging Software for Lung Diseases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for AI Medical Imaging Software for Lung Diseases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for AI Medical Imaging Software for Lung Diseases is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key AI Medical Imaging Software for Lung Diseases players cover Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of AI Medical Imaging Software for Lung Diseases market by product type, application, key players and key regions and countries.

Segmentation by Type:
Pulmonary Nodules
Pneumonia
Other

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Pulmonary Nodules
Pneumonia
Other

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Riverain Technologies
Deepwise
Shukun Technology
Infervision Medical
United-Imaging
Yizhun Intelligent
VoxelCloud
Fosun Aitrox
Huiying Medical
BioMind

Please note: The report will take approximately 2 business days to prepare and deliver.